MedPath

PowerLIFE Anelsa Capsule

Registration Number: MAL20016206T

Approved
Approval ID

788e3fcac245af76

Registration Number

MAL20016206T

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types5 types
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (5)

180 CapsulesAvailable
Package Size: 180 Capsules
Status: NPRA Approved
120 CapsulesAvailable
Package Size: 120 Capsules
Status: NPRA Approved
90 CapsulesAvailable
Package Size: 90 Capsules
Status: NPRA Approved
60 CapsulesAvailable
Package Size: 60 Capsules
Status: NPRA Approved
30 CapsulesAvailable
Package Size: 30 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (3)

Eleutherococcus senticosusActive
Monograph: eleutherococcus senticosus
Sambucus nigraActive
Andrographis paniculataActive

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PowerLIFE Anelsa Capsule - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform